DIGITAL VACCINES

Serial Number 87258838
606

Registration Progress

Application Filed
Dec 6, 2016
Under Examination
Aug 13, 2019
Approved for Publication
Dec 26, 2017
Published for Opposition
Dec 26, 2017
Registered

Trademark Image

DIGITAL VACCINES

Basic Information

Serial Number
87258838
Filing Date
December 6, 2016
Published for Opposition
December 26, 2017
Abandonment Date
September 19, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 19, 2022
Classes
042

Rights Holder

MODERNATX, INC.

03
Address
200 Technology Square, 2nd Floor
CAMBRIDGE, MA 02139

Ownership History

MODERNATX, INC.

Original Applicant
03
Cambridge, MA

MODERNATX, INC.

Owner at Publication
03
CAMBRIDGE, MA

Legal Representation

Attorney
Keith Barritt

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description Documents
Sep 19, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 19, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 8, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 7, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 3, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 3, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 25, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 25, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 25, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 11, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 11, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 29, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 27, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 27, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 27, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 24, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 22, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 22, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 22, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 17, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 17, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 15, 2019 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 13, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 1, 2019 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
Jul 1, 2019 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Jul 1, 2019 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
Jun 29, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 29, 2018 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 26, 2018 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Jan 22, 2018 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Dec 26, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 26, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 6, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 19, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 13, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 13, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 13, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 25, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 25, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 25, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 8, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 9, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 9, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development in the fields of pharmaceuticals, biologics, biosimilars, and biotherapeutics consisting of genetically engineered medicines that are physically administered into the human body

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"VACCINES"